Source link : https://newshealth.biz/health-news/fda-approves-first-biosimilar-to-omalizumab/
The US Food and Drug Administration (FDA) has approved the first biosimilar form of omalizumab (Xolair) for the treatment of a range of allergic conditions. Omalizumab-igec (Omlyclo) is designed for the same four indications as its reference drug: Allergic asthma, chronic rhinosinusitis with nasal polyps, chronic unexplained hives, and food allergies. The approval “will help broaden […]
The post FDA Approves First Biosimilar to Omalizumab first appeared on News Health.
Author : News Health
Publish date : 2025-03-13 10:01:00
Copyright for syndicated content belongs to the linked Source.
in Health